Skip to main content

Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1816))

Abstract

Specific cell lineages differentiated from human induced pluripotent stem cells (iPSCs) are promising sources for cell replacement therapy and are useful biomedical research tools for research on disease mechanisms and drug discovery. Among the different lineages, cardiac lineage has been one of the most efficiently differentiated through several established protocols. In this chapter, we describe our reproducible and highly efficient methodology for differentiating iPSCs into cardiomyocytes using embryoid bodies. We also describe methods to dissociate iPSC-derived cardiomyocytes and to evaluate iPSC-derived cardiomyocytes.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Burridge PW, Keller G, Gold JD et al (2012) Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 10:16–28

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mummery CL, Zhang J, Ng ES et al (2012) Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 111:344–358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Protze SI, Liu J, Nussinovitch U et al (2017) Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker. Nat Biotechnol 35:56–68

    Article  CAS  PubMed  Google Scholar 

  4. Lee JH, Protze SI, Laksman Z et al (2017) Human pluripotent stem cell-derived atrial and ventricular cardiomyocytes develop from distinct mesoderm populations. Cell Stem Cell 21:179–194.e4

    Article  CAS  PubMed  Google Scholar 

  5. Yang L, Soonpaa MH, Adler ED et al (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453:524–528

    Article  CAS  PubMed  Google Scholar 

  6. Kattman SJ, Witty AD, Gagliardi M et al (2011) Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8:228–240

    Article  CAS  PubMed  Google Scholar 

  7. Willems E, Spiering S, Davidovics H et al (2011) Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ Res 109:360–364

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dubois NC, Craft AM, Sharma P et al (2011) SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 29:1011–1018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Elliott DA, Braam SR, Koutsis K et al (2011) NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 8:1037–1040

    Article  CAS  PubMed  Google Scholar 

  10. Miki K, Endo K, Takahashi S et al (2015) Efficient detection and purification of cell populations using synthetic MicroRNA switches. Cell Stem Cell 16:699–711

    Article  CAS  PubMed  Google Scholar 

  11. Funakoshi S, Miki K, Takaki T et al (2016) Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep 6:19111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We greatly appreciate colleagues at our laboratories and the Department of Cardiovascular Medicine, Kyoto University. We thank Gordon Keller, Mark Gagliardi, Shunsuke Funakoshi, and Chikako Okubo for providing valuable advice and support for the differentiation method of cardiomyocytes, Ikue Takei, Misato Nishikawa, Azusa Inagaki, and Megumi Narita for technical support, and Peter Karagiannis for proofediting. We would like to express our heartfelt gratitude to Yoko Uematsu for her administrative support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshinori Yoshida .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Hatani, T., Miki, K., Yoshida, Y. (2018). Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies. In: Ishikawa, K. (eds) Experimental Models of Cardiovascular Diseases. Methods in Molecular Biology, vol 1816. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8597-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8597-5_6

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-8596-8

  • Online ISBN: 978-1-4939-8597-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics